Literature DB >> 32458880

An insight into the role of riboflavin ligand in the self-assembly of poly(lactic-co-glycolic acid)-based nanoparticles - a molecular simulation and experimental approach.

Sima Rezvantalab1, Mostafa Keshavarz Moraveji1, Mohammad Khedri1, Reza Maleki2.   

Abstract

Nanoparticles (NPs) used for targeted delivery purposes are rapidly gaining importance in diagnostic and therapeutic fields. These agents have been studied extensively so far to reveal their optimal physicochemical properties including the effects of ligands and their density on the surface of NPs. This article was conducted through a computational approach (all-atom molecular dynamics simulations) to predict the stability of NPs based on a poly-lactic-co-glycolic acid (PLGA) hydrophobic core with a poly-ethylene glycol (PEG) hydrophilic shell and varying numbers of riboflavin (RF) molecules as ligands. Depending on the molecular weight of the polymers, the most stable composition of NPs was achieved at 20 wt% and 10 wt% PLGA-PEG-RF for PLGA3kDa-PEG2kDa and PLGA4.5kDa-PEG2kDa polymers, respectively. According to the simulations, riboflavin molecules were located on the surface of the NPs, which would indicate that riboflavin-bound PLGA-PEG NPs could be efficiently utilized for active targeting purposes. To scrutinize the simulation results, NPs with riboflavin ligands were synthesized and put into in vitro experiments. Outstandingly, the empirical outcomes revealed that the hydrodynamic sizes of NPs also met minimum points at 20 and 10 wt% for PLGA3kDa-PEG2kDa and PLGA4.5kDa-PEG2kDa, respectively. Moreover, similar trends in the gyration radius as a function of riboflavin content were observed in the simulation analysis and the experimental results, which would indicate that the method of molecular dynamics (MD) simulation is a reliable mathematical technique and could be applied for predicting the physicochemical properties of NPs.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32458880     DOI: 10.1039/d0sm00203h

Source DB:  PubMed          Journal:  Soft Matter        ISSN: 1744-683X            Impact factor:   3.679


  7 in total

1.  Novel pH-responsive nanohybrid for simultaneous delivery of doxorubicin and paclitaxel: an in-silico insight.

Authors:  Ehsan Alimohammadi; Reza Maleki; Hossein Akbarialiabad; Mohammad Dahri
Journal:  BMC Chem       Date:  2021-02-11

2.  Shedding Light on Miniaturized Dialysis Using MXene 2D Materials: A Computational Chemistry Approach.

Authors:  Pegah Zandi; Ebrahim Ghasemy; Mohammad Khedri; Alimorad Rashidi; Reza Maleki; Ahmad Miri Jahromi
Journal:  ACS Omega       Date:  2021-02-25

3.  Molecular insight into optimizing the N- and P-doped fullerenes for urea removal in wearable artificial kidneys.

Authors:  Ahmad Miri Jahromi; Pegah Zandi; Mohammad Khedri; Ebrahim Ghasemy; Reza Maleki; Lobat Tayebi
Journal:  J Mater Sci Mater Med       Date:  2021-04-23       Impact factor: 3.896

4.  Molecular engineering of the last-generation CNTs in smart cancer therapy by grafting PEG-PLGA-riboflavin.

Authors:  Somayeh Sohrabi; Mohammad Khedri; Reza Maleki; Mostafa Keshavarz Moraveji
Journal:  RSC Adv       Date:  2020-11-09       Impact factor: 4.036

5.  Graphene-Based Nanoparticles as Potential Treatment Options for Parkinson's Disease: A Molecular Dynamics Study.

Authors:  Ehsan Alimohammadi; Mohammad Khedri; Ahmad Miri Jahromi; Reza Maleki; Milad Rezaian
Journal:  Int J Nanomedicine       Date:  2020-09-18

6.  Engineering the pH-Sensitivity of the Graphene and Carbon Nanotube Based Nanomedicines in Smart Cancer Therapy by Grafting Trimetyl Chitosan.

Authors:  Azadeh Khoshoei; Ebrahim Ghasemy; Fatemeh Poustchi; Mohammad-Ali Shahbazi; Reza Maleki
Journal:  Pharm Res       Date:  2020-08-03       Impact factor: 4.200

7.  Biomolecular engineering of drugs loading in Riboflavin-targeted polymeric devices: simulation and experimental.

Authors:  Mohammad Khedri; Mostafa Keshavarz Moraveji
Journal:  Sci Rep       Date:  2022-03-24       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.